Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes

Journal of Experimental Medicine - Tập 199 Số 12 - Trang 1631-1640 - 2004
Melissa B. Uccellini1, Courtney Broughton2, Fabienne Mackay3, Shizuo Akira4, Ann Marshak‐Rothstein5, Ian R. Rifkin2
1Renal Section, Department of Medicine, Boston University School of Medicine, EBRC 5th Floor, 650 Albany Street, Boston, MA 02118, USA.
21Renal Section, Department of Medicine
33Department of Arthritis and Inflammation, Garvan Institute of Medical Research, New South Wales 2010, Australia
4Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
5Department of Microbiology, Boston University School of Medicine, Boston, MA 02118

Tóm tắt

Dendritic cell (DC) activation by nucleic acid–containing immunoglobulin (Ig)G complexes has been implicated in systemic lupus erythematosus (SLE) pathogenesis. However, the mechanisms responsible for activation and subsequent disease induction are not completely understood. Here we show that murine DCs are much more effectively activated by immune complexes that contain IgG bound to chromatin than by immune complexes that contain foreign protein. Activation by these chromatin immune complexes occurs by two distinct pathways. One pathway involves dual engagement of the Fc receptor FcγRIII and Toll-like receptor (TLR)9, whereas the other is TLR9 independent. Furthermore, there is a characteristic cytokine profile elicited by the chromatin immune complexes that distinguishes this response from that of conventional TLR ligands, notably the induction of BAFF and the lack of induction of interleukin 12. The data establish a critical role for self-antigen in DC activation and explain how the innate immune system might drive the adaptive immune response in SLE.

Từ khóa


Tài liệu tham khảo

1996, Cell., 85, 303, 10.1016/S0092-8674(00)81108-3

1998, Nat. Genet., 19, 56, 10.1038/ng0598-56

2000, Nat. Genet., 25, 177, 10.1038/76032

1999, Nat. Med., 5, 694, 10.1038/9544

2002, J. Exp. Med., 196, 135, 10.1084/jem.20012094

2001, Nature., 411, 207, 10.1038/35075603

1990, J. Clin. Invest., 86, 69, 10.1172/JCI114716

2001, J. Rheumatol., 28, 81

1991, Immunol. Today., 12, 301, 10.1016/0167-5699(91)90003-C

2001, Nat. Genet., 28, 313, 10.1038/91070

2003, Annu. Rev. Immunol., 21, 685, 10.1146/annurev.immunol.21.120601.141040

2002, Nat. Rev. Immunol., 2, 965, 10.1038/nri957

2000, J. Exp. Med., 191, 411, 10.1084/jem.191.3.411

2000, Eur. J. Immunol., 30, 3591, 10.1002/1521-4141(200012)30:12<3591::AID-IMMU3591>3.0.CO;2-J

2002, J. Exp. Med., 195, 1653, 10.1084/jem.20020338

2002, Nat. Immunol., 3, 822, 10.1038/ni829

2003, Annu. Rev. Immunol., 21, 231, 10.1146/annurev.immunol.21.120601.141152

1999, J. Exp. Med., 190, 1697, 10.1084/jem.190.11.1697

2000, Nature., 404, 995, 10.1038/35010115

2001, J. Immunol., 166, 6, 10.4049/jimmunol.166.1.6

1999, J. Immunol., 163, 6306, 10.4049/jimmunol.163.11.6306

2001, Science., 294, 1540, 10.1126/science.1064890

2003, Proc. Natl. Acad. Sci. USA., 100, 2610, 10.1073/pnas.0337679100

2001, Immunity., 15, 435, 10.1016/S1074-7613(01)00196-0

2002, Nature., 416, 603, 10.1038/416603a

1998, Immunity., 9, 143, 10.1016/S1074-7613(00)80596-8

2000, Nature., 408, 740, 10.1038/35047123

2000, J. Immunol., 165, 1626, 10.4049/jimmunol.165.3.1626

1990, J. Immunol. Methods., 134, 187, 10.1016/0022-1759(90)90380-E

1990, J. Clin. Invest., 85, 1487, 10.1172/JCI114595

2003, Immunity., 19, 837, 10.1016/S1074-7613(03)00323-6

1998, J. Immunol., 160, 4755, 10.4049/jimmunol.160.10.4755

2002, Nat. Immunol., 3, 196, 10.1038/ni758

1995, Nature., 374, 163, 10.1038/374163a0

2001, Eur. J. Immunol., 31, 3026, 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H

2002, J. Immunol., 169, 3652, 10.4049/jimmunol.169.7.3652

2003, Nature., 424, 324, 10.1038/nature01783

2001, Antisense Nucleic Acid Drug Dev., 11, 247, 10.1089/108729001317022241

2003, DNA Cell Biol., 22, 621, 10.1089/104454903770238094

1995, Clin. Immunol. Immunopathol., 75, 140, 10.1006/clin.1995.1063

2003, J. Immunol., 170, 2549, 10.4049/jimmunol.170.5.2549

1999, J. Exp. Med., 189, 371, 10.1084/jem.189.2.371

2001, Nat. Immunol., 2, 675, 10.1038/90609

2001, Nature., 413, 732, 10.1038/35099560

2001, Trends Immunol., 22, 78, 10.1016/S1471-4906(00)01811-1

1997, J. Exp. Med., 185, 1977, 10.1084/jem.185.11.1977

2003, Antisense Nucleic Acid Drug Dev., 13, 143, 10.1089/108729003768247600

1998, J. Immunol., 160, 1122, 10.4049/jimmunol.160.3.1122

2001, Annu. Rev. Immunol., 19, 275, 10.1146/annurev.immunol.19.1.275

2002, Immunity., 16, 157, 10.1016/S1074-7613(02)00275-3

2002, Nat. Rev. Immunol., 2, 580, 10.1038/nri856

1999, Immunol. Rev., 172, 279, 10.1111/j.1600-065X.1999.tb01372.x

2002, J. Exp. Med., 195, 125, 10.1084/jem.20011097

2002, J. Exp. Med., 195, F1, 10.1084/jem.20011925

1995, Nature., 374, 546, 10.1038/374546a0

1991, J. Immunol., 147, 1759, 10.4049/jimmunol.147.6.1759

1999, Proc. Natl. Acad. Sci. USA., 96, 2285, 10.1073/pnas.96.5.2285

2001, J. Immunol., 167, 2602, 10.4049/jimmunol.167.5.2602

2001, Scand. J. Immunol., 54, 543, 10.1046/j.1365-3083.2001.01018.x

2003, Immunology., 109, 255, 10.1046/j.1365-2567.2003.01653.x

2002, Eur. J. Immunol., 32, 1958, 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U

2004, Nat. Immunol., 5, 190, 10.1038/ni1028

2002, Genes Dev., 16, 2662, 10.1101/gad.1022802

2003, Nat. Immunol., 4, 138, 10.1038/ni881

2002, J. Immunol., 168, 4531, 10.4049/jimmunol.168.9.4531

2001, J. Exp. Med., 194, 863, 10.1084/jem.194.6.863

1987, Trends Genet., 3, 342, 10.1016/0168-9525(87)90294-0

2002, Annu. Rev. Immunol., 20, 709, 10.1146/annurev.immunol.20.100301.064842

1997, Genomics., 40, 454, 10.1006/geno.1996.4598

1998, Proc. Natl. Acad. Sci. USA., 95, 12631, 10.1073/pnas.95.21.12631

2001, Blood., 97, 198, 10.1182/blood.V97.1.198

2003, J. Exp. Med., 197, 297, 10.1084/jem.20021343

2004, J. Biol. Chem., 279, 12542, 10.1074/jbc.M310175200

2004, Science., 303, 1526, 10.1126/science.1093620

2004, Science., 303, 1529, 10.1126/science.1093616

2004, Proc. Natl. Acad. Sci. USA., 101, 5598, 10.1073/pnas.0400937101

2003, J. Immunol., 171, 3154, 10.4049/jimmunol.171.6.3154

1998, Nature., 392, 245, 10.1038/32588